Sequential vs concurrent chemoradiation for stage III non–small cell lung cancer: randomized phase III trial RTOG 9410

…, R Komaki, JS Lee, S Hauser, B Movsas… - Journal of the …, 2011 - academic.oup.com
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared
with TRT alone has been shown to confer a survival advantage for good performance status …

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

…, CA Lawton, RE Krisch, HB Wolkov, B Movsas… - International Journal of …, 2005 - Elsevier
Purpose: Radiation Therapy Oncology Group protocol 85–31 was designed to evaluate the
effectiveness of adjuvant androgen suppression, using goserelin, in unfavorable prognosis …

Randomized trial of amifostine in locally advanced non–small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy …

B Movsas, C Scott, C Langer… - Journal of clinical …, 2005 - ascopubs.org
Purpose To test the ability of the cytoprotectant, amifostine, to reduce chemoradiotherapy-induced
esophagitis and evaluate its influence on quality of life (QOL) and swallowing …

[HTML][HTML] Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non–small-cell lung cancer: an analysis of RTOG 9801

B Movsas, J Moughan, L Sarna, C Langer… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
… Provision of study materials or patients: Benjamin Movsas, Corey Langer, Maria Werner-Wasik,
Nicos Nicolaou, Ritsuko Komaki, Mitchell Machtay Collection and assembly of data …

Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines

WJ Scott, J Howington, S Feigenberg, B Movsas… - Chest, 2007 - Elsevier
Background The surgical treatment of stage I and II non-small cell lung cancer (NSCLC)
continues to evolve in the areas of intraoperative lymph node staging (specifically the issue of …

Pulmonary radiation injury

B Movsas, TA Raffin, AH Epstein, CJ Link - Chest, 1997 - journal.chestnet.org
T he fundamental ability to successfully treat any neoplasm ultimately depends on the
therapeutic ratio, ie, the ability to sterilize the tumor while sparing normal tissues. There are t:\vo …

Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases

…, JH Suh, WF Demas, B Movsas… - Journal of the …, 2005 - academic.oup.com
Background: Radiation therapy is effective in palliating pain from bone metastases. We
investigated whether 8 Gy delivered in a single treatment fraction provides pain and narcotic …

[HTML][HTML] Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer

…, AA Konski, R Stoyanova, B Movsas… - Journal of Clinical …, 2013 - ncbi.nlm.nih.gov
… Buyyounouski, Augmenix (C), GE Healthcare (C) Stock Ownership: None Honoraria:
Alan Pollack, Varian Medical Systems, Accuray, Siemens Healthcare Research Funding …

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions

…, TE Schultheiss, WH Pinover, B Movsas… - International Journal of …, 1998 - Elsevier
Purpose: To report the 5-year outcomes of dose escalation with 3D conformal treatment (3DCRT)
of prostate cancer. Methods and Materials: Two hundred thirty-two consecutive …

Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline

…, K Latzka, SS Lo, D Moghanaki, B Movsas… - Practical radiation …, 2017 - Elsevier
Purpose This guideline presents evidence-based recommendations for stereotactic body
radiation therapy (SBRT) in challenging clinical scenarios in early-stage non-small cell lung …